Nanobiotix (NBTX) Total Liabilities: 2021-2025

  • Nanobiotix's Total Liabilities rose 10.61% to $129.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $246.8 million, marking a year-over-year increase of 109.22%. This contributed to the annual value of $142.3 million for FY2024, which is 37.36% up from last year.
  • As of Q2 2025, Nanobiotix's Total Liabilities stood at $129.2 million, which was down 9.19% from $142.3 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Total Liabilities registered a high of $142.3 million during Q4 2024, and its lowest value of $363,866 during Q2 2022.
  • Moreover, its 3-year median value for Total Liabilities was $116.8 million (2024), whereas its average is $98.3 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first decreased by 0.94% in 2022, then skyrocketed by 27,978.05% in 2024.
  • Quarterly analysis of 5 years shows Nanobiotix's Total Liabilities stood at $367,303 in 2021, then dropped by 0.94% to $363,866 in 2022, then climbed by 14.32% to $103.0 million in 2023, then soared by 38.10% to $142.3 million in 2024, then increased by 10.61% to $129.2 million in 2025.
  • Its Total Liabilities was $129.2 million in Q2 2025, compared to $142.3 million in Q4 2024 and $116.8 million in Q2 2024.